Esperion Therapeutics
ESPR
#6752
Rank
A$0.73 B
Marketcap
$3.72
Share price
-3.57%
Change (1 day)
149.51%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -A$58.3 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are A$0.27 Billion. In 2023 the company made an earning of -A$0.24 Billion, an increase over its 2022 earnings that were of -A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$58.3 Million-74.69%
2023 -A$0.24 Billion-15.03%
2022 -A$0.28 Billion-20.61%
2021 -A$0.35 Billion84.28%
2020 -A$0.19 Billion35.75%
2019 -A$0.14 Billion-55.71%
2018 -A$0.31 Billion19.57%
2017 -A$0.26 Billion125.39%
2016 -A$0.12 Billion51.43%
2015 -A$75.51 Million36.45%
2014 -A$55.34 Million43.55%
2013 -A$38.55 Million145.26%
2012 -A$15.72 Million
2002 -A$44.81 Million-7.81%
2001 -A$48.61 Million15.03%
2000 -A$42.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.59 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.86 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.61 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.16 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.31 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA